M
Monteris Medical
Health Tech & Medtech · Plymouth, United States · Founded 1999
A medical device venture developing new technologies for the treatment of cancer MoreLess
Monteris Medical is a pioneering medical technology company specializing in minimally invasive brain surgery solutions. The company's flagship product, NeuroBlate, is a laser ablation system designed to treat neurological lesions, including brain tumors and epileptic foci, with precision and minimal invasiveness. NeuroBlate integrates advanced software, disposables, and hardware to provide a comprehensive solution for healthcare professionals. Monteris Medical operates in the healthcare sector, primarily serving neurosurgeons and their patients. The company generates revenue through the sale of its NeuroBlate system and associated disposables, as well as through ongoing clinical trials and research initiatives. Monteris Medical's market includes hospitals, medical centers, and specialized neurosurgery clinics. The business model focuses on providing cutting-edge technology that improves patient outcomes while reducing the risks associated with traditional open neurosurgical procedures. The company's innovative approach and commitment to advancing medical technology position it as a leader in the field of minimally invasive neurosurgery.
Keywords: laser ablation, brain surgery, NeuroBlate, minimally invasive, neurological lesions, brain tumors, epileptic foci, healthcare technology, neurosurgery, medical innovation.
Company overview
Monteris Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 1999
- Headquarters
- Plymouth, United States
- Employees
- 128
- Open positions
- 3
- Dealroom signal
- 52.8
Valuation & funding
Monteris Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Mar 2026 | $28M | $175M | Undisclosed | ↗ |
| DEBTDebt | Mar 2026 | $35M | — | Trinity Capital | ↗ |
| DEBTDebt | Oct 2022 | $38M | — | Madryn Asset Management | ↗ |
| SERIES DOther financing | Oct 2022 | $35M | $140M | Birchview Capital · InnovaHealth Partners | ↗ |
| LATE VCOther financing | Sep 2022 | $14M | $150M | Undisclosed | ↗ |
| DEBTDebt | Mar 2020 | Undisclosed | — | ||
| SERIES DOther financing | Jan 2019 | Undisclosed | — | ||
| SERIES COther financing | Jun 2017 | SightLine Partners · Versant Ventures | — | ||
| DEBTDebt | Nov 2016 | Undisclosed | — | ||
| DEBTDebt | Jun 2016 | Oxford Finance | — |
Growth signals
Monteris Medical website traffic
Latest recorded traffic for Monteris Medical is 3.8K monthly website visits, up 8.6% over the last three months. Monteris Medical's team grew 6.7% over the past year.
Hiring
Open positions at Monteris Medical
Current openings linked to this company in Dealroom.
Comparisons
Monteris Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Monteris Medical's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Monteris Medical has talent and traffic
team presence
In the news
Latest news about Monteris Medical
Recent press, funding announcements, and product moves mentioning Monteris Medical — open to read from the original sources.
Market sentiment
What the market is saying about Monteris Medical
An AI-synthesized read of the highest-engagement posts about Monteris Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Monteris Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.


















